9.19. Analysis.
Comparison 9 Vaginal ring releasing etonogestrel 120 µg + EE 15 µg versus COC drospirenone 3 mg + EE 30 µg, Outcome 19 Total number of adverse events (cycle 12).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.